Author(s): Varada Soujanya, Revu Baby Nalanda
DOI: 10.52711/0974-360X.2023.00992
Views:
13
(pdf),
1337
(html)
Access:
Open Access
Cite: Varada Soujanya, Revu Baby Nalanda. Analytical method development and validation for the estimation of Rilpivirine and its N-Oxide impurity using UPLC. Research Journal of Pharmacy and Technology. 2023; 16(12):6110-6. doi: 10.52711/0974-360X.2023.00992
Read More
|
Author(s): Varada Soujanya, Revu Baby Nalanda
DOI: 10.52711/0974-360X.2024.00093
Views:
0
(pdf),
1324
(html)
Access:
Open Access
Cite: Varada Soujanya, Revu Baby Nalanda. Method development and validation for the simultaneous estimation of Doultegravir and Rilpivirine related impurities (Rilpivirine Z Isomer and Dolutegravir hydroxy impurity) using RP HPLC. Research Journal of Pharmacy and Technology. 2024; 17(2):595-2. doi: 10.52711/0974-360X.2024.00093
Read More
|
Author(s): Asia, Revu Baby Nalanda;
DOI: 10.52711/0974-360X.2025.00055
Views:
0
(pdf),
870
(html)
Access:
Closed Access
Cite: Asia, Revu Baby Nalanda, Method development and validation for the simultaneous quantification of Rilpivirine and Cabotegravir in rabbit plasma using UPLC-MS/MS. Research Journal of Pharmacy and Technology. 2025;18(1):355-0. doi: 10.52711/0974-360X.2025.00055
Read More
|
Author(s): Asia, Revu Baby Nalanda
DOI: 10.52711/0974-360X.2025.00241
Views:
0
(pdf),
727
(html)
Access:
Closed Access
Cite: Asia, Revu Baby Nalanda. Development and validation of a new stability indicating RP-UFLC method for the quantification of Molnupiravir. Research Journal of Pharmacy and Technology. 2025;18(4):1680-7. doi: 10.52711/0974-360X.2025.00241
Read More
|